Robbins Mark L, Paiva Andrea L, Amoyal Nicole R, Brick Leslie, Kessler Debra A, Burditt Caitlin, Caltabiano Melinda, Shaz Beth H
University of Rhode Island, Kingston, RI, USA
University of Rhode Island, Kingston, RI, USA.
Health Promot Pract. 2015 Mar;16(2):227-35. doi: 10.1177/1524839914533344. Epub 2014 May 6.
A pilot test of a computer-tailored intervention designed to promote blood donation among Blacks was conducted.
Intervention content, based on the transtheoretical model, offered participants individually and culturally tailored information on blood donation with emphasis on need specific to race (e.g., sickle-cell disease). Black adults (N = 150) with a diversity of blood donation experience were recruited from a blood center and a survey recruitment website. Posttest assessment included a 14-item evaluation and transtheoretical model questions.
Participants rated the program positively (81.3% to 98.7% of participants agreeing or strongly agreeing with evaluation items). For example, 98.7% of respondents reported that the program gave sound advice and that personal feedback was easily understood, and 87.3% felt the program was designed for people like themselves. Ninety-five percent of participants reported that they would recommend the program to others. There were no significant differences in ratings based on demographics. Qualitative responses support program acceptability. Furthermore, pre- and postprogram assessments indicated an increase in intention to donate, t(149) = 3.56, p = .001, d = .29.
With acceptability and feasibility confirmed, the next steps are to test efficacy and cost-effectiveness for use to increase blood donation, particularly in priority populations.
开展了一项计算机定制干预措施的试点测试，该措施旨在促进黑人献血。
基于跨理论模型的干预内容为参与者提供了个性化且符合文化背景的献血信息，重点强调了特定种族的需求（例如镰状细胞病）。从一个血液中心和一个调查招募网站招募了150名有不同献血经历的黑人成年人。测试后评估包括一个14项的评价和跨理论模型问题。
参与者对该项目评价积极（81.3%至98.7%的参与者同意或强烈同意评价项目）。例如，98.7%的受访者表示该项目给出了合理建议且个人反馈易于理解，87.3%的人认为该项目是为像他们这样的人设计的。95%的参与者表示他们会向他人推荐该项目。基于人口统计学的评分没有显著差异。定性回答支持项目的可接受性。此外，项目前后评估表明献血意愿有所增加，t(149)=3.56，p=.001，d=.29。
在确认了可接受性和可行性之后，下一步是测试其有效性和成本效益，以用于增加献血量，特别是在优先人群中。
